Home » Newsletters » BioWorld MedTech

BioWorld MedTech

Sep. 8, 2014

View Archived Issues

Sequenom purchases Dragen Bio-IT processor for faster data analysis

Inside the Beltway: Journal articles argue for expanded use of CT for lung cancer screening

Asia in the Spotlight: Japanese government looking to promote domestic devices and drugs

Teleflex gets results of peer-reviewed study of antithrombogenic PICC

World In Review: Medtronic gets CE mark for CoreValve Evolut R System

MDD Stock Watch

Patent Watch: Pacific Edge gains patent for melanoma prognostic test

Agreements/contracts: ResMed and Apex settle patent disputes over sleep apnea products

Daily M&A: Mednax completes acquisition of MedData in cash transaction

Financings: Beddit's funding totals $8 million with closing of latest funding round

People in Places

Briefly Noted

product briefs

MDD's Neurology Extra

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...